Literature DB >> 2964944

Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction.

J B Michel1, A L Lattion, J L Salzmann, M L Cerol, M Philippe, J P Camilleri, P Corvol.   

Abstract

To explain how converting enzyme inhibition could improve the prognosis in cardiac insufficiency, the effect of converting enzyme inhibition (CEI) by S9490-3 (Perindopril) treatment for 2 months (treated infarctions, n = 18) on hormonal plasma variables and the quantitative and qualitative changes in myocardium were studied in an experimental model of left ventricular infarction in rats (untreated infarctions, n = 18) and compared to a sham-operated control group (n = 15). Induction of myocardial infarction was associated with a transient decrease in blood pressure. CEI treatment maintained a lower blood pressure throughout the experimental period. Plasma renin concentration was not significantly increased in the untreated infarct group (155.4 +/- 136.7 ng AI/ml/hr) as compared to the sham-operated group (47.6 +/- 15.9 ng AI/ml/hr). Plasma aldosterone did not change in the three experimental groups. The plasma level of immunoreactive atrial natriuretic factor increased in the untreated infarct group (185 +/- 245 pg/ml) as compared with the control group (76 +/- 40 pg/ml) and was normalized by CEI (66 +/- 60 pg/ml). Body weight was slightly decreased in both treated and untreated infarct groups, whereas the heart weight was significantly increased in the untreated group (1,540 +/- 310 mg) and normalized by treatment (1,145 +/- 180 mg) as compared with sham-operated controls (1,071 +/- 80 mg). The combined atria and right ventricular mass was significantly increased in the untreated infarct group (660 +/- 210 mg) and decreased by treatment (443 +/- 106 mg) but was not completely normalized (controls, 343 +/- 40 mg). Left ventricular isomyosin profiles were modified by myocardial infarction as compared with controls: V1 form decreased from 62.4 +/- 9.4% in the sham-operated group to 41.6 +/- 13.4% in the infarct group, and the V3 form increased from 13.0 +/- 4.7% in sham-operated animals to 27.4 +/- 11.8% in untreated infarct animals. CEI treatment partially, but significantly, reversed this modification of the isomyosin profile (V1, 53.0 +/- 14.4%; V3, 17.5 +/- 8.0%). Volume density of collagen was significantly increased in the untreated infarct rats (4.14 +/- 0.81% versus 2.68 +/- 0.49% in controls), and this was reversed by treatment (2.95 +/- 0.66%). Messenger RNA encoding for atrial natriuretic factor, measured by dot blot hybridization, was significantly increased in both the atria and the ventricles in the untreated infarct group, and treatment by CEI partially reversed this increase. Thus, myocardial infarction profoundly modified several variables of peripheral circulation and quantitative and qualitative myocardial protein expression.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2964944     DOI: 10.1161/01.res.62.4.641

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  28 in total

1.  Ventricular remodelling after myocardial infarction.

Authors:  M A Vannan; D J Taylor
Journal:  Br Heart J       Date:  1992-09

2.  Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology.

Authors:  Martin Ugander; Abiola J Oki; Li-Yueh Hsu; Peter Kellman; Andreas Greiser; Anthony H Aletras; Christopher T Sibley; Marcus Y Chen; W Patricia Bandettini; Andrew E Arai
Journal:  Eur Heart J       Date:  2012-01-24       Impact factor: 29.983

Review 3.  Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs.

Authors:  R J MacFadyen; K R Lees; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

4.  Shear stress triggers insertion of voltage-gated potassium channels from intracellular compartments in atrial myocytes.

Authors:  Hannah E Boycott; Camille S M Barbier; Catherine A Eichel; Kevin D Costa; Raphael P Martins; Florent Louault; Gilles Dilanian; Alain Coulombe; Stéphane N Hatem; Elise Balse
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-24       Impact factor: 11.205

Review 5.  ACE inhibitors in acute and chronic ischaemia: current status and future promise.

Authors:  E H Sonnenblick; M Zhao; C Eng; T H LeJemtel; S M Factor; J Capasso; P Anversa
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

Review 6.  Perindopril. A review of its pharmacokinetics and clinical pharmacology.

Authors:  R J Macfadyen; K R Lees; J L Reid
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 7.  Myocardial repair/remodelling following infarction: roles of local factors.

Authors:  Yao Sun
Journal:  Cardiovasc Res       Date:  2008-12-02       Impact factor: 10.787

8.  Alteration of collagenous protein profile in congestive heart failure secondary to myocardial infarction.

Authors:  V Pelouch; I M Dixon; R Sethi; N S Dhalla
Journal:  Mol Cell Biochem       Date:  1993-12-22       Impact factor: 3.396

Review 9.  Role of extracellular matrix proteins in heart function.

Authors:  V Pelouch; I M Dixon; L Golfman; R E Beamish; N S Dhalla
Journal:  Mol Cell Biochem       Date:  1993-12-22       Impact factor: 3.396

10.  Losartan inhibits myosin isoform shift after myocardial infarction in rats.

Authors:  Mei Luo Zhang; Samer Elkassem; Allen W Davidoff; Kaoru Saito; Henk E D J ter Keurs
Journal:  Mol Cell Biochem       Date:  2003-09       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.